“HCRN is incredibly supportive at any phase of development – from LOI to budget development, protocol development, and organizing biospecimens. They offer tremendous resources for investigators.”

Carey K. Anders, MD, medical oncologist, Duke Health, Durham, N.C.; co-chair, HCRN Breast Cancer Clinical Trial Working Group

“HCRN has been a great platform for investigators to meet regularly and collaborate on important research ideas, ultimately facilitating partnerships with industry to efficiently advance the science.”

Alan Tan, MD, Director of GU Medical Oncology, Rush Medical Center, Chicago, IL.

“HCRN serves as a platform for investigators to vet their ideas with other research leaders across multiple institutions and for investigators to collaborate among each other, refine protocols, and make connections with industry partners.”

Erica Stringer-Reasor, MD, associate professor, University of Alabama at Birmingham (UAB), Birmingham, AL; co-chair, HCRN Breast Cancer Clinical Trial Working Group